AFA
Abacus FCF Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,574
| Closed | -$1.22M | – | 294 |
|
|
2024
Q3 | $1.22M | Sell |
10,574
-463
| -4% | -$53.3K | 0.28% | 121 |
|
|
2024
Q2 | $1.52M | Buy |
+11,037
| New | +$1.52M | 0.38% | 104 |
|
|
2024
Q1 | – | Sell |
-8,783
| Closed | -$1.16M | – | 157 |
|
|
2023
Q4 | $1.16M | Buy |
+8,783
| New | +$1.16M | 0.34% | 102 |
|